NACE 74.90 in FR. Official registry identity, filed financial evidence and a rounded indicative valuation range on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2021. This is not a current market value or asking price.
Based on filed company accountsCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for MEDS uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
MEDS is a business in NACE sector 74.90 based in France. It is incorporated as a 5710.
MEDS is listed in French National Business Register (RNE/INPI) under registry number 882096076. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 74.90 cluster, public-record data is filed annually via the national company registry.
Across the 2020-2021 window revenue has moderated, moving from €979,800 to €786,783.
The most recent annual filing covers 2021 (period end 2021-12-31).
If you are researching MEDS for acquisition, investment, or due-diligence purposes, this page consolidates its firmographics, multi-year filings, and a historical indicative range based on the latest available public filing, not a current market value.
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202131 Dec 2021 | €786,783 | - | €475,880 | €417,472 | - |
| 202031 Dec 2020 | €979,800 | - | €1,176,590 | €669,476 | - |
MEDS is registered under NACE 74.90: NACE 74.90. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2021 (period end 2021-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows a rounded historical indicative range for MEDS, based on the latest available public filing for fiscal year 2021. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
